Apollo Hospitals Group has entered into a partnership with India Medtronic Pvt Ltd, part of global medical technology major Medtronic, to advance stroke management using artificial intelligence (AI) in India, the companies said in a joint statement on Thursday. Through this partnership, Medtronic will help in bringing in stroke technologies, technical expertise, training, and comprehensive stroke management with the integration of AI platform at the Apollo Institute of Neurosciences at 10 locations in Apollo Hospitals across the country, the statement said.
This will take stroke management to the next level by standardizing stroke diagnosis and empowering clinicians to make a faster, more accurate diagnosis and treatment decisions, it added. “This partnership brings together Apollo Hospitals” clinical expertise, AI platform and stroke technologies from Medtronic to transform stroke treatment in the country,” Apollo Hospitals Group Chairman Prathap C Reddy stated.
AI has been a boon for the healthcare industry and has transformed many different aspects from drug development to diagnostics and clinical medicine and surgery, he added. “We are aiming to address the current treatment gaps in stroke with our innovative technologies, aiming at reducing the door to needle time, thereby potentially improving outcomes for patients,” Medtronic Indian Subcontinent Vice-President Madan Krishnan said.
As per a recent PTI report, he added that the company’s partnership with Apollo Hospitals will further its goal of creating awareness and providing quicker access to quality healthcare for stroke patients in India. Headquartered in Dublin, Ireland, Medtronic is among the world’s largest medical technology, services, and solutions companies. It employs more than 90,000 people worldwide, serving physicians, hospitals, and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare further, together.
Last updated: December 26th, 2025
